KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Revenue (2016 - 2025)

Merck (MRK) has disclosed Revenue for 17 consecutive years, with $16.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Revenue rose 4.97% to $16.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $65.0 billion, a 1.31% increase, with the full-year FY2025 number at $65.0 billion, up 1.31% from a year prior.
  • Revenue was $16.4 billion for Q4 2025 at Merck, down from $17.3 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $17.3 billion in Q3 2025 to a low of $10.6 billion in Q1 2021.
  • A 5-year average of $14.9 billion and a median of $15.3 billion in 2023 define the central range for Revenue.
  • Biggest YoY gain for Revenue was 123.89% in 2021; the steepest drop was 11.86% in 2021.
  • Merck's Revenue stood at $13.5 billion in 2021, then grew by 2.29% to $13.8 billion in 2022, then increased by 5.78% to $14.6 billion in 2023, then grew by 6.79% to $15.6 billion in 2024, then increased by 4.97% to $16.4 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Revenue are $16.4 billion (Q4 2025), $17.3 billion (Q3 2025), and $15.8 billion (Q2 2025).